4//SEC Filing
Scavilla Daniel T 4
Accession 0000950170-24-130588
CIK 0001237831other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:29 PM ET
Size
11.7 KB
Accession
0000950170-24-130588
Insider Transaction Report
Form 4
Scavilla Daniel T
DirectorPresident, CEO
Transactions
- Exercise/Conversion
Class A Common Stock
2024-11-21$43.58/sh+80,000$3,486,400→ 130,000 total - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2024-11-21−50,000→ 0 totalExercise: $43.77Exp: 2028-01-22→ Class A Common Stock (50,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy Class A Common Stock)
2024-11-21−80,000→ 0 totalExercise: $43.58Exp: 2029-01-22→ Class A Common Stock (80,000 underlying) - Exercise/Conversion
Class A Common Stock
2024-11-21$43.77/sh+50,000$2,188,500→ 50,000 total - Sale
Class A Common Stock
2024-11-21$85.00/sh−130,000$11,050,000→ 0 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan dated June 7, 2024 executed by the reporting person.
- [F2]These options were granted on January 22, 2018 and are fully vested.
- [F3]These options were granted on January 22, 2019 and are fully vested.
Documents
Issuer
GLOBUS MEDICAL INC
CIK 0001237831
Entity typeother
Related Parties
1- filerCIK 0001642439
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 4:29 PM ET
- Size
- 11.7 KB